Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development (Q38074989)

28 August 2017

1 reference

title

Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development (English)

1 reference

28 August 2017

0 references

1 reference

Michael W Sinz

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

28 August 2017

published in

Drug Metabolism Reviews

1 reference

28 August 2017

volume

45

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

3-14

1 reference

Understanding nuclear receptors using computational methods

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Orphan nuclear receptors--new ligands and new possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Structure and function of the human nuclear xenobiotic receptor PXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Application and interpretation of hPXR screening data: Validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Development of a UGT1A1 reporter gene assay for induction studies: correlation between reporter gene data and regulation of UGT1A1 in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Evaluation of models for predicting drug–drug interactions due to induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Further studies with the 2-amino-1,3-thiazol-4(5H)-one class of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: reducing pregnane X receptor activity and exploring activity in a monkey pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Cytochrome P450 and xenobiotic receptor humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Machine learning methods and docking for predicting human pregnane X receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Evaluation of cynomolgus monkey pregnane X receptor, primary hepatocyte, and in vivo pharmacokinetic changes in predicting human CYP3A4 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Quantitative relationship between rifampicin exposure and induction of Cyp3a11 in SXR humanized mice: extrapolation to human CYP3A4 induction potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Discovery of a highly active ligand of human pregnane x receptor: a case study from pharmacophore modeling and virtual screening to "in vivo" biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

An insulin-like growth factor 1 receptor inhibitor induces CYP3A4 expression through a pregnane X receptor-independent, noncanonical constitutive androstane receptor-related mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Current in vitro high throughput screening approaches to assess nuclear receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

New opportunities for pregnane X receptor (PXR) targeting in drug development. lessons from Enantio- and species-specific PXR ligands identified from a discovery library of amino acid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Implications and consequences of enzyme induction on preclinical and clinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602532.2012.743560

10.3109/03602532.2012.743560

21 January 2018

Identifiers

DOI

1 reference

release_du4q2cr3e5f2zihx2kahswksj4

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/du4q2cr3e5f2zihx2kahswksj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference